NPS-1034 is primarily used in research settings as a selective agonist for the GPR35 receptor, making it a valuable tool for studying G protein-coupled receptor signaling pathways. It is employed in pharmacological studies to investigate the role of GPR35 in inflammatory processes, metabolic regulation, and gastrointestinal function. Due to its high selectivity and potency, NPS-1034 helps researchers elucidate receptor-specific effects without significant off-target interactions. It is also utilized in assays to screen potential drug candidates targeting GPR35-related diseases, including type 2 diabetes, irritable bowel syndrome, and certain cancers. Its application remains confined to preclinical research and is not used in therapeutic or industrial contexts.